Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-28 4:22 pm Sale | 2022-06-24 | 13D | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | ORBIMED ADVISORS LLC | 3,534,537 6.900% | -306,027 (-7.97%) | Filing History |
| 2022-05-05 4:56 pm Purchase | 2022-05-03 | 13D | PASSAGE BIO INC PASG | ORBIMED ADVISORS LLC | 342,071 12.600% | 44,705 (+15.03%) | Filing History |
| 2022-04-08 5:20 pm Sale | 2022-04-06 | 13D | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | ORBIMED ADVISORS LLC | 3,840,564 7.600% | -427,000 (-10.01%) | Filing History |
| 2022-04-01 5:06 pm Unchanged | 2022-03-29 | 13D | PMV PHARMACEUTICALS INC PMVP | ORBIMED ADVISORS LLC | 6,589,330 14.500% | 0 (Unchanged) | Filing History |
| 2022-03-15 4:30 pm Unchanged | 2022-03-10 | 13D | SIERRA ONCOLOGY INC SRRA | ORBIMED ADVISORS LLC | 3,044,753 12.200% | 0 (Unchanged) | Filing History |
| 2022-02-11 5:09 pm Sale | 2021-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | ORBIMED ADVISORS LLC | 631,000 1.220% | -1,080,305 (-63.13%) | Filing History |
| 2022-02-11 5:08 pm Purchase | 2021-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | ORBIMED ADVISORS LLC | 61,212 6.400% | 12 (+0.02%) | Filing History |
| 2022-02-11 4:58 pm Purchase | 2021-12-31 | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | ORBIMED ADVISORS LLC | 350,641 5.300% | 24,681 (+7.57%) | Filing History |
| 2022-02-11 4:57 pm Unchanged | 2021-12-31 | 13G | VERRICA PHARMACEUTICALS INC VRCA | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:51 pm Purchase | 2021-12-31 | 13G | VECTIVBIO HLDG AG VECT | ORBIMED ADVISORS LLC | 4,903,504 14.000% | 73,500 (+1.52%) | Filing History |
| 2022-02-11 4:49 pm Sale | 2021-12-31 | 13G | THERAVANCE BIOPHARMA INC TBPH | ORBIMED ADVISORS LLC | 5,456,780 7.400% | -87,432 (-1.58%) | Filing History |
| 2022-02-11 4:48 pm Sale | 2021-12-31 | 13G | STRONGBRIDGE BIOPHARMA PLC SHS SBBP | ORBIMED ADVISORS LLC | 0 0.000% | -2,986,869 (Position Closed) | Filing History |
| 2022-02-11 4:46 pm Purchase | 2021-12-31 | 13G | SONENDO INC SONX | ORBIMED ADVISORS LLC | 9,841 7.500% | 9,841 (New Position) | Filing History |
| 2022-02-11 4:42 pm Purchase | 2021-12-31 | 13G | RXSIGHT INC RXST | ORBIMED ADVISORS LLC | 1,062,500 3.900% | 1,062,500 (New Position) | Filing History |
| 2022-02-11 4:40 pm Purchase | 2021-12-31 | 13G | PROTARA THERAPEUTICS INC TARA | ORBIMED ADVISORS LLC | 671,741 6.000% | 671,741 (New Position) | Filing History |
| 2022-02-11 4:39 pm Sale | 2021-12-31 | 13G | PANDION THERAPEUTICS INC PAND | ORBIMED ADVISORS LLC | 0 0.000% | -1,040,825 (Position Closed) | Filing History |
| 2022-02-11 4:38 pm Sale | 2021-12-31 | 13G | OTONOMY INC OTIC | ORBIMED ADVISORS LLC | 0 0.000% | -2,480,800 (Position Closed) | Filing History |
| 2022-02-11 4:35 pm Unchanged | 2021-12-31 | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 4,012,281 16.500% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:31 pm Purchase | 2021-12-31 | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | ORBIMED ADVISORS LLC | 6,063,345 5.590% | 1,544,989 (+34.19%) | Filing History |
| 2022-02-11 4:30 pm Sale | 2021-12-31 | 13G | MEIRAGTX HLDGS PLC MGTX | ORBIMED ADVISORS LLC | 3,593,966 8.100% | -375,459 (-9.46%) | Filing History |